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Lipid raft Sphingomyelin(PUFA) constitute an inﬂuential group of molecules that promote health by an
as yet unknown mechanism. They are structurally distinguished from less unsaturated fatty acids by the
presence of a repeating fCH–CH2–CHf unit that produces an extremely ﬂexible chain rapidly reorienting
through conformational states. The most highly unsaturated case in point is docosahexaenoic acid (DHA)
with 6 double bonds. This review will summarize how the high disorder of DHA affects the properties of
the membrane phospholipids into which the PUFA incorporates, focusing upon the profound impact on
the interaction with cholesterol. Results obtained with model membranes using an array of biophysical
techniques will be presented. They demonstrate DHA and the sterol possesses a mutual aversion that
drives the lateral segregation of DHA-containing phospholipids into highly disordered domains away from
cholesterol. These domains are compositionally and organizationally the opposite of lipid rafts, the
ordered domain enriched in predominantly saturated sphingolipids “glued” together by cholesterol that is
believed to serve as the platform for signaling proteins. We hypothesize that DHA-rich domains also form
in the plasma membrane and are responsible, in part, for the diverse range of health beneﬁts associated
with DHA.
© 2008 Elsevier B.V. All rights reserved.Contents
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While in general the importance of membrane structure cannot
be doubted, details of how membranes function at a molecular level
remain elusive. In fact, despite the solid foundation laid by decades317 274 2393.
ll rights reserved.of membrane research [1–3], understanding the mechanisms of
membrane function is one of the major outstanding problems
confronting the life sciences. Membranes surround every living cell
that has ever existed and were likely an essential component of the
ﬁrst cell. If membranes are so important and ubiquitous, why then
do we know so little about them? A typical membrane is over-
whelmingly complex, consisting of as many as 1500 different lipid
species and a hundred or more different proteins all in rapid ﬂux [4].
Table 1
Human conditions affected by DHA levels
ADHD Depression Multiple sclerosis
Aggression Dermatitis Neurovisual developmental
disorders
Alcoholism Diabetes Nephropathy
Alzheimer's disease Dyslexia Periodontitis
Arthritis Eczema Phenylketonuria
Asthma Fertility Placental function
Atrial ﬁbrillation Gingivitis Psoriasis
Autism Heart disease Respiratory diseases
Bipolar disorder Hypersensitivity Schizophrenia
Blindness Inﬂammatory response Sperm fertility




Brain development Malaria visual acuity Visual acuity
Cancer Methylmelonic acidaemia Zellweger's syndrome
Crohn's disease Migraine headaches
Cystic ﬁbrosis Mood and behavior
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a membrane at a given instant, a microsecond later everything
would have changed. Due to the large number of chemical species
involved and the vast range of size- and time-scales required to
study membranes, a wide variety of often-esoteric experimental
techniques must be simultaneously employed.
One approach has been to investigate membrane structure from
the perspective of a single component [5]. It is the approach that our
laboratories have taken and is the focus of this review. We study how
polyunsaturated fatty acids (PUFA), particularly docosahexaenoic acid
(DHA, 22:6Δ4,7,10,13,16,19) shown in Fig. 1, affect membrane structure,
dynamics and function. DHA is of special interest because with 22
carbons and 6 double bonds it is the most unsaturated and one of the
longest fatty acids comprising the membrane hydrophobic core [6].
We believe that this unusual fatty acid, while exhibiting some
properties similar to other more common, shorter and less unsatu-
rated membrane fatty acids, will nevertheless alter membrane
structure in a unique and measurable fashion. In addition DHA
represents the extrememember of a family of fatty acids known asω3
PUFA that are believed to provide relief for a wide variety of human
health problems [7,8]. An abbreviated list of these reputed beneﬁts is
found in Table 1. They can be roughly separated into some 6 non-
exclusive categories: heart disease, cancer, immune function, neuronal
function, aging and “other” hard to categorize problems such as
migraine headaches, malaria and sperm fertility [7]. While some links
of DHA and health arewell established, others are the result of a single
report and are at best controversial. Nevertheless it is clear that DHA
levels do exert profound effects on signiﬁcant physiological processes.
The elusive question is how one seemingly simple molecule can do so
many different things. We postulate that at least a portion of the
beneﬁts attributed to DHA can be ascribed to its role in membrane
dynamics and structure.
2. Membrane structure
It is now universally accepted that biological membranes are not
homogeneous mixtures of lipid and protein but instead are composed
of rapidly changing arrangements of widely differing membrane
patches called domains [1–3]. Domains are proposed to exhibit
different sizes, stabilities, lipid and protein compositions, and
functions. Some domains are macroscopic and stable for extended
time periods and so are isolatable and well deﬁned. Most of the
membrane, however, is likely composed of an enormous number of
poorly understood and less stable lipid microdomains [2]. While there
are compelling reasons to believe that lipid domains exist, and theyFig. 1. Molecular structure of docosahexaenoic acid (DHA) and cholesterol.have been clearly demonstrated in model lipid monolayer and bilayer
membranes, they are difﬁcult to study, and so far, impossible to isolate
in pure form from biological membranes [2,3]. Unfortunately, most
demonstrations of lipid domains depend on equivocal interpretation
of biophysical measurements.
Formation of lipid domains is the consequence of unequal afﬁnities
between different lipid species or between lipids and membrane
proteins. Lipid domain size has beenproposed to range between tens of
molecules or so (1–10 nm) to large domains on the μm scale [2]. The
most studied lipid domains are the result of lateral phase separation
between gel and liquid crystalline clusters in protein-free phospholipid
monolayers and bilayers. Domains resulting from ﬂuid–ﬂuid phase
separations, while much harder to demonstrate, are likely the most
signiﬁcant domain types in biological membranes [9]. By far the best
documented of the ﬂuid–ﬂuid domains are phospholipids/cholesterol
mixtures that have been shown to segregate into cholesterol-rich
(liquid-ordered, lo) and cholesterol-poor (liquid-disordered, ld) lipid
domains [10] and sphingomyelin (SM)-rich phase-separated mem-
branes [11,12]. If lipid domainsdo indeedexist in a livingmembrane, it is
reasonable to predict that each distinct domainwould attract different
proteins and so would support different biochemical functions. In
addition, domain boundaries would be locations of high membrane
instability and so would support increased permeability, ﬂip-ﬂop,
fusion, enzymeactivities, etc. [5]. The cell's biochemistryandphysiology
would therefore directly reﬂect domain structure and composition, and
the domains in turnwould be affected by dietary fatty acids.
Recently, there has been considerable interest in one reputed type
of lipid domain termed a raft [11,13]. Rafts are sphingolipid and
cholesterol-rich lo domains ﬂoating in a sea of ld phospholipids [11–
15]. Their biological interest stems from a close association of rafts
with essential cell signaling proteins including lipid-linked proteins
such as the src family of kinases in the inner leaﬂet and GPI-anchored
proteins in the outer leaﬂet of plasmamembranes [3,11,16]. An original
hallmark of rafts is their insolubility in cold non-ionic detergents,
often Triton X-100. The isolated detergent-insoluble fractions (a.k.a.
detergent resistant membranes or DRM) are indeed enriched in
cholesterol and sphingolipid and signiﬁcantly contain characteristic
membrane signaling proteins [3,11,16]. While DRM mark the begin-
nings of raft studies, they are fraught with artifacts and are being
replaced by gentler, detergent-free methods [17]. Although the small
(and apparently ever decreasing) size of domains in biological
membranes [2,3] precludes unequivocal imaging, their existence has
been inferred by a variety of biophysical techniques including NMR,
ESR, ﬂuorescence, X-ray diffraction, and differential scanning calori-
metry (DSC) [4]. It is likely, moreover, that numerous proteins may
migrate between domains in response to alterations in membrane
lipid composition. This concept has been at the heart of our research.
Table 2
A summary comparing the physical properties of DHA- and OA-containing PC




Area/molecule, monolayer (Å2) 70c 63d 1.11 [41]
Area/molecule, bilayer (Å2) 69.2 61.4 1.13 [42]
Bilayer permeability
Water (μm/s) 412 155 2.66 [45]
Carboxyﬂuorescein (% leakage) 35 15 2.33 [46]
Dithionite (s−1) 0.017 0.005 3.40 [47]
Erythritol (d(1/A)dt×10−2 s−1) 8.1 3.9 2.08 [46]
Mechanical properties
Fusion (pmol/106 cells) 24.8 2.9 8.55 [46]
Flip-ﬂop (h−1) 2.4 0.061 39.34 [47]
Elasticity/compressibility, bilayer (Ka dyne/cm)) 121 221 0.55 [42]
Elasticity/compressibility, monolayer (Cs−1 mN/m) 108c 123d 0.88 [41]
a 18:0–22:6PC unless otherwise stated.
b 18:0–18:1PC unless otherwise stated.
c 16:0–22:6PC.
d 16:0–18:1PC.
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In mammals DHA is found in extraordinarily high concentrations,
occasionally exceeding 50 mol% of the total acyl chains, only in select
tissues [6] that includesynaptosomes [18], sperm[19]and the retinal rod
outer segment [20]. Dipolyunsaturated phospholipidswith DHA at both
sn-1 and -2 positions have even been identiﬁed in these tissues [21,22].
The already high DHA levels in these specialized membranes are not
further augmented by diet and, once incorporated, DHA is tenaciously
retained at the expense of other fatty acids [6]. In sharp contrast to the
few tissues containing high levels of DHA are the other tissues where
DHA is normally found well below 5 mol% of the total acyl chains. In
these tissues DHA can be enriched 2–10 fold through dietary
supplementation with foods, notably ﬁsh oils, rich in this ω3 PUFA
[6,23]. Here DHA would primarily be found in the sn-2 chain of
phospholipids with the sn-1 chain mainly composed of the saturated
fattyacidspalmitic (16:0)or stearic (18:0)acid [24]. It isDHA'sauspicious
dietary augmentation in the “low-DHA” membranes that we believe
may be responsible in part for the reputed health beneﬁts of DHA.
It has been well documented that DHA is rapidly incorporated
into a variety of cells, primarily into phospholipids of the plasma
membrane [25] and mitochondria [26,27]. However, DHA is not
distributed equally in all phospholipid classes. In most reported
studies DHA was shown to be preferentially esteriﬁed to PE
(phosphatidylethanolamine) with lesser amounts to PC (phosphati-
dylcholine) and other phospholipid classes [28,29]. DHA-accumula-
tion into PE, however, is not a hard-and-fast rule as Salem et al. [6]
have reported that in synaptosomal membranes DHA is often found
associated with PS (phosphatidylserine). DHA-containing PE has also
been shown to preferentially accumulate in the PE- and PS-rich inner
leaﬂet of several membranes [29–31]. The implication is that DHA-
containing phospholipids are heterogeneously distributed in mem-
branes, and that domains rich and poor in this PUFA exist.
This review will address two basic questions about the function of
DHA in membranes. First we will brieﬂy discuss whether DHA is
indeed different than another very common but much less unsatu-
rated fatty acid, oleic acid (OA, 18:1Δ9). We will then address in much
greater detail the interaction of DHA with the most common lipid in
mammalian plasma membranes, the sterol cholesterol.
4. DHA vs. OA
To better understand the mechanism of DHA-induced membrane
phase separations that will be discussed later, we begin by comparing
the physical properties of DHA to those of the most common
unsaturated fatty acid, OA. A repeating fCH–CH2–CHf unit is what
distinguishes PUFA from less unsaturated fatty acids. This pattern has a
profound impact on molecular conformation that was demonstrated by
the energy-minimized structures modeled in the pioneering work by
Applegate and Glomset [32,33]. The shallow potential energy well for
rotation about the single C–C bonds that separate the unsaturated
carbon atoms in this pattern produces an extremely ﬂexible, highly
disordered structure [34]. DHA chains isomerize so rapidly that they
explore their entire conformational space within 50 ns [35]. The
torsional states adopted include bent conﬁgurations that bring even the
lower portions of the PUFA chain up to the membrane surface [36–38].
As a result DHA-containing phospholipids “pack loosely” [5], have a
tendency to form non-lamellar phases [39] and can induce negative
curvature strain to adjacent membrane lipids and proteins [40]. These
properties are not associated with OA-containing phospholipids.
There have been numerous studies reporting the effect of DHA-
containing phospholipids on basic physical properties of lipid bilayers
and monolayers. A few of them, comparing hetero-acid saturated
(16:0 or 18:0)-unsaturated PC with DHA or OA at the sn-2 position, are
summarized below and listed in Table 2. The reported properties are
divided into three categories:4.1. Physical dimensions
Smaby et al. [41] used pressure/area isotherms on monolayers to
demonstrate that 16:0–22:6PC (70 Å2) occupies an area about 11%
larger than 16:0–18:1PC (63 Å2). Employing a combination of NMR
and X-ray diffraction, Koenig et al. [42] measured a similar
differential in molecular area in bilayers. They reported an area for
18:0–22:6PC (69.2 Å2) that is about 13% larger than 18:0–18:1PC
(61.4 Å2). These observations and a subsequent high precision X-ray
determination of comparably large surface area per molecule for
18:0–22:6PC (68.2 Å2) [43] are consistent with the surprising fact
that membranes rich in DHA, such as the rod outer segment
membrane where DHA levels approach 50% of the total acyl chains,
are actually quite thin [44]. The tremendously high disorder of DHA
chains, causing them to reorient through a large cross-sectional area,
reduces their effective length [36–38].
4.2. Bilayer permeability
One would expect that poorly packed and thin membranes should
also be quite permeable. This prediction was conﬁrmed by several
differentmeasurements. By 17ONMRHuster et al. [45] saw that bilayers
composed of 18:0–22:6PC are 2.7× more permeable to water than
18:0–18:1PC. Higher permeability for 18:0–22:6PC than 18:0–18:1PC
was similarly followed by carboxyﬂuorescein leakage (2.3×) [46],
dithionite permeability (3.4×) [47] and erythritol swelling (2.1×) [46].
4.3. Mechanical properties
Substituting DHA for OA has also been shown to have a large
effect on the basic membrane properties of fusion, ﬂip-ﬂop and
elastic compressibility. In a comparison of fusion rates in sonicated
unilamellar vesicles (SUV) composed of either 18:0–22:6PC or 18:0–
18:1PC with cultured T27A tumor cells, the DHA-containing vesicles
were found to be 8.6× more fusogenic than the OA-containing
vesicles [46]. Using dithionite bleaching of NBD-PE to monitor ﬂip-
ﬂop in large unilamellar vesicles (LUV), an enhancement of 39× in
the rate for ﬂip-ﬂop was seen when 18:0–22:6PC replaced 18:0–
18:1PC [47]. Finally, the lateral compressibility modulus for DHA- vs.
OA-containing PC was compared by two different methods. Koenig et
al. [42] introduced polyethylene glycol (PEG) to apply osmotic
gradients that impart lateral pressure to the membrane and
determined compressibility on the basis of a combination of order
parameter and lamellar repeat spacing derived from 2H NMR and
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about 1.8× more compressible (lower modulus) than 18:0–18:1PC.
Results in qualitative agreement, indicating 16:0–22:6PC is about
1.1× more compressible than 16:0–18:1PC, were obtained from
pressure-area isotherms on monolayers by Smaby et al. [41].
From the experiments summarized in Table 2, it is obvious that
the multiple double bonds that DHA possesses in addition to OA
have a profound effect on membrane structure [48]. The phenome-
nal ﬂexibility of DHA chains produces a much more dynamic
membrane interior. DHA-rich membranes are thin, ﬂuid and loosely
“packed”, tremendously compressible, very permeable and support
high rates of membrane lipid ﬂip-ﬂop [48]. Increased water
permeability, for example, makes membranes enriched in DHA
“wetter” [45] than OA-rich membranes. The elevated fusion rates
reported for DHA-containing model membranes [46] are consistent
with the presence of the PUFA in biological membranes known to
naturally exhibit high levels of fusion or the reverse process of
exfoliation (sperm, rod outer segment and synaptosomes) [6].
Therefore, on the basis of these and other similar experiments we
conclude that DHA confers upon membranes dynamic characteristics
that the far more abundant OA cannot.
Since all lipids undergo rapid lateral diffusion in the membrane
leaﬂet plane [49], during their excursion through themembrane DHA-
containing phospholipids must encounter hundreds of other lipid
species. The afﬁnity or aversion that DHA has for these lipids has the
potential to drive the formation and to determine the eventual
stability of PUFA-rich membrane domains. Cholesterol is the lipid that
has been of particular interest to us. DHA–cholesterol interactions and
the segregation into domains they promote will be the focus of the
remainder of this review.
5. DHA has an aversion for cholesterol
Cholesterol consists of a rigid tetracyclic ring structure with a
hydroxyl group at one end and a short hydrocarbon tail at the other (Fig.
1). The sterol is abundant in mammalian plasma membranes, account-
ing for as much as 50% total lipid [50]. It globally modulates molecular
organization and the unequal afﬁnity it possesses for different lipids
drives the formation of domains [51]. The interaction of cholesterolwith
phosphoplipid, especially PC, model membranes has been extensively
examined [52]. When incorporated into homoacid disaturated PC
membranes, the rigid steroid moiety disrupts the regular packing of
chains in the gel (a.k.a. solid ordered, so) phase and restricts the
reorientation of the fatty acid chains in the lamellar liquid crystalline Lα
(a.k.a. ld) phase [53]. The differential between the phases is smeared out
with increasing amounts of sterol until lo phase, characterized by rapid
reorientation but high conformational order, is adopted over a wide
range of temperatures at concentrations N25 mol%. Excess sterol is
expelled after the content exceeds N50 mol% [54]. Within the
membrane, the steroid moiety lines up approximately parallel to the
acyl chains with the hydroxyl group situated near the aqueous interface
and the short side-chain extended towards the centre of themembrane
[55]. There is rapid rotation about the long molecular axis that wobbles
through a narrow range of angles slightly tilted relative to the bilayer
normal [56]. Heteroacid saturated-monounsaturated PCs exhibit com-
parable behavior in the presence of cholesterol [57–59].
The relatively few studies published on heteroacid saturated–
polyunsaturated PC membranes imply that the addition of choles-
terol has the same general effect as seen in homoacid disaturated
and heteroacid saturated-monounsaturated PCs [59–61]. Like mem-
branes where the sn-2 chain is saturated or monounsaturated, PC
membranes with a PUFA chain at the sn-2 position become more
ordered in the physiologically relevant liquid crystalline state and
the sterol reorients rapidly around its “wobbling” long molecular
axis. This qualitative resemblance in behavior belies the cholesterol-phobia possessed by PUFA. The high disorder of polyunsaturated
chains is responsible. Their rapidly changing conformation pushes
away the rigid steroid moiety of a neighboring cholesterol molecule
[62]. The predominantly all-trans conﬁguration adopted by a
saturated chain, on the contrary, presents a smooth façade that is
compatible with intimate contact with the sterol [62]. Recent
experimental and computer modeling work support this view. In
1H MAS NMR experiments on 18:0–22:6PC/[25,26,26,26,27,27,27-
2H7]cholesterol (1:1 mol) membranes, closer contact with the
18:0 sn-1 chain is revealed by a higher rate of chain-to-cholesterol
nuclear Overhauser enhancement cross-relaxation [63]. Molecular
dynamics (MD) simulations on 18:0–22:6PC/cholesterol (3:1 mol)
corroborate that the sterol favors solvation by saturated over
polyunsaturated chains [64]. As there is a series of 9 saturated
carbons prior to the double bond in OA that facilitates near approach
to the steroid moiety [65], the monounsaturated fatty acid would not
be expected to share the poor afﬁnity for cholesterol associated with
PUFA. An ability for the sterol to pack well around the mono-
unsaturated, as well as the saturated, chain in 16:0–18:1PC is indeed
indicated by recent MD simulations [66].
Measurements of sterol-induced condensation of lipid monolayers
give an early example of indirect experimental evidence that
cholesterol has an aversion for PUFA. The percentage reduction in
averagemolecular areawith respect to the (ideal) weighted average of
the molecular areas of the individual components at a given surface
pressure serves as an indicator of relative strength of interaction.
Whereas cholesterol condenses monolayers made from disaturated
and heteroacid saturated-unsaturated PCs containing OA, heteroacid
saturated-unsaturated PCs containing DHA do not condense [67,68].
That rapid inter-conversion between conformational states imbued by
the recurring fCH–CH2–CHf motif in PUFA deters close proximity to
the steroid moiety is conﬁrmed by a comparison of monolayers
prepared from isomeric PCs with 18:0 acid at the sn-1 position and
polyunsaturated α-linolenic (α18:3) or γ-linolenic (γ18:3) acid at the
sn-2 position [69]. Appreciable vs. negligible area condensation is
exerted by the sterol on 18:0–α18:3PC and 18:0–γ18:3PC, respec-
tively. The determinant is whether the sequence of double bonds
occurs below, as for the 9, 12 and 15 positions in the α-isomer, or
above, as for the 6, 9 and positions in the γ-isomer, the depth towhich
the steroid moiety penetrates the monolayer. Partition coefﬁcients
recently measured for cholesterol in large unilamellar vesicles (LUV)
using a cyclodextrin assay offer a more deﬁnitive estimate of strength
of interaction [70]. They are smaller in vesicles composed of PC with
DHA than less unsaturated chains such as OA, the value for
dipolyunsaturated 22:6–22:6PC being even smaller than for 18:0–
22:6PC with only a single PUFA chain.
The ﬁrst unequivocal demonstration of poor afﬁnity for choles-
terol was provided by the greatly reduced solubility seen in PUFA-
containing membranes. This ﬁnding was initially inferred from the
small intensity of NMR signals acquired from cholesterol mixed in
equimolar amount with dipolyunsaturated 22:6–22:6PC and 1,2-dia-
rachidonylphosphatidylcholine (20:4–20:4PC) membranes [59,63].
Most of the sterol did not contribute to the signal because it was
outside the membrane, which contrasts with less unsaturated
membranes that can accommodate ≥50 mol% cholesterol [54]. A
quantitative estimate of the reduction in solubility was obtained in
solid state 2H NMR work, followed-up by X-ray diffraction experi-
ments [59,71–74]. Both methods detect sterol that has been excluded
from a membrane to measure the solubility [71]. The NMR-based
result is based upon a comparison of the integrated intensity of
signals simultaneously observed from membrane-incorporated and -
excluded deuterated analogs of cholesterol. In the case of X-ray
diffraction, the solubility limit above which cholesterol is excluded
from the membrane is revealed by the concentration of added sterol
at which diffraction peaks due to solid cholesterol monohydrate
begin to appear. A graphical comparison of measurements on DHA-
Fig. 2. Solubility of cholesterol in OA- and DHA-containing PC (top panel) and PE
(bottom panel) membranes. All samples were in the lamellar liquid crystalline state
except 22:6–22:6PE that was in the inverted hexagonal HII phase. Values were taken for
16:0–18:1PC from Huang et al. [54], for 18:0–22:6PC and 22:6–22:6PC from
Brzustowicz et al. [72], and for 16:0–18:1PE, 16:0–22:6PE and 22:6–22:6PE from
Shaikh et al. [74].
Fig. 3. Schematic representation of the tipped-over orientation for cholesterol in
dipolyunsaturated 20:4–20:4PC membranes discovered by neutron scattering [58,75].
The sterol lies ﬂat between leaﬂets in the middle of the bilayer.
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branes is presented in Fig. 2. Reduced values are clearly associated
with the PUFA. The reduction is accentuated for PC and PE
possessing DHA at both sn-1 and -2 positions, revealing that the
sterol is pushed out of these membranes where PUFA chains cannot
be avoided at a concentration N3× lower than in the mixed chain
saturated–polyunsaturated equivalents [72,74]. As opposed to 18:0–
22:6PC with a saturated sn-1 chain that can accommodate 55±3 mol
% cholesterol despite having a DHA chain attached at the sn-2
position, there is decreased solubility in heteroacid saturated–
polyunsaturated 16:0–22:6PE (31±3 mol%) as well as homoacid
dipolyunsaturated 22:6–22:6PE [74]. The additional sensitivity of PE
is ascribed to its smaller headgroup and resultant smaller cross-
sectional area. This more closely packed arrangement would to tend
to force sterol and PUFA together within the membrane, exacerbat-
ing their mutual adverse interaction and exclusion of the sterol from
the membrane.
Neutron scattering experiments elaborate the unique nature of the
aversion cholesterol has for PUFA [58,75]. This experimental approach
relies on the difference in sign and magnitude of the scattering
amplitude for deuterium and hydrogen. Scattering length density
(SLD) calculated from the difference between proﬁles obtained with
labeled and unlabeled analogs of cholesterol incorporated into aligned
multilayers identify the location of the labeled position(s) on the
deuterated analog as a pair of peaks symmetrically placed about the
middle of the bilayer. In the generally accepted arrangement where
the long molecular axis of the sterol lines up parallel to the fatty acids
chains in each leaﬂet of the bilayer, the label on [2,2,3,4,4,6-2H6]
cholesterol (head-labeled analog) appears near the aqueous interface
approximately ±16 Å from the bilayer center while that on
[25,26,26,26,27,27,27-2H7]cholesterol (tail-labeled analog) is at the
center. Remarkably, the results obtained with aligned multilayers of20:4–20:4PC completely devoid of saturated fatty acid reveal that the
center of mass of deuterium in both head- and tail-labeled analogs
resides in the middle of the membrane. The PUFA chains push away
cholesterol so strongly that, as schematically represented in Fig. 3, the
sterol is tipped over to lie ﬂat between leaﬂets. There the molecule
rapidly reorients about its long axis, undergoing whole body motion
that is constrained within ±6 Å [75].
A propensity for PUFA to push cholesterol over from its usual
orientation, in which the hydroxyl group of the steroid moiety is
anchored at the aqueous interface, to the interior of the membrane
would facilitate ﬂip-ﬂop of the sterol from one side to the other of a
membrane. This notion is supported by recently published coarse
grained (CG) simulations on arachidonic acid-containing PC bilayers
[76]. In these simulations enhanced rates of ﬂip-ﬂop were observed
for cholesterol and the presence of sterol embedded between
monolayers was also identiﬁed. The implication is that poor afﬁnity
for PUFA has the potential to affect the trans-membrane, as well as the
lateral, distribution of cholesterol in plasma membranes. PUFA
preferentially incorporate into phospholipids, such as PE, that are
more abundant in the inner leaﬂet [31] and would drive the transfer of
cholesterol to the outer layer where sphingolipids are primarily found
[16]. A substantial redistribution of cholesterol to the outer leaﬂet,
moreover, has been reported following accumulation of PUFA into
plasma membranes [77].
6. DHA aversion for cholesterol promotes the formation
of domains
The poor afﬁnity that PUFA have for cholesterol drives, we
hypothesize, the formation of domains concentrated in PUFA-contain-
ing phospholipids but depleted in the sterol [5,10,48,78]. The highly
disordered environment within these domains is the absolute
antithesis of the ordered one that exists in lipid rafts enriched in
predominantly saturated sphingolipids and cholesterol [62,79].
Because dipolyunsaturated phospholipids are most incompatible
with cholesterol, they have the greatest tendency to separate into
Fig. 4. Percentage of PE, cholesterol (CHOL) and SM in the DSM fraction of 16:0–22:6PE/
egg SM/cholesterol (1:1:1 mol) (left) and 16:0–18:1PE/egg SM/cholesterol (1:1:1 mol)
(right) membranes treatedwith 1% Triton X-100 at 4 °C. Each value is relative to the total
amount of the speciﬁc lipid in detergent-soluble and -insoluble fractions [81].
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measurements on bovine rhodopsin reconstituted into 16:0–16:0PC/
22:6–22:6PC/cholesterol bilayer mixtures imply cholesterol induces
separation of 16:0–16:0PC into sterol-enriched domains and of 22:6–
22:6PC into clusters around the protein [80]. These experiments
employed lipids labeled in the headgroup with pyrene as donor and
the retinal group of rhodopsin as acceptor. Higher FRET efﬁciency for
the dipolyunsaturated species was detected only in the presence
of the sterol. A radius of 35 Å was the size envisaged for the clusters of
22:6–22:6PC molecules with the protein, equivalent to two annular
layers of lipid. This radius is compatible with the size of 20:4–20:4PC
domains estimated on the basis of 2H NMR data for 18:0–20:4PC/
20:4–20:4PC/[3α-2H1]cholesterol (1:1:2 mol) [71]. The spectrum for
the mixed membrane was interpreted in terms of [3α-2H1]cholesterol
partitioning into 18:0–20:4PC and 20:4–20:4PC domains in accor-
dance with its solubility of 49 and 17 mol% in each lipid, respectively.
An upper limit of b160 Å was then assigned to the domains assuming
that lateral diffusionmediates fast exchange (at a rate greater than the
differential in quadrupolar splitting for [3α-2H1]cholesterol in sterol-
poor and -rich domains) between the regions.
Dipolyunsaturated phospholipid domains that are depleted of
cholesterol have been proposed to provide the ld environment
necessary for the function of rhodopsin in the disk membrane of the
rod outer segment [80]. Apart from neural [18,20,21] and a few other
specialized [19,22] membranes where DHA is abundant, however,
dipolyunsaturated phospholipids with PUFA sn-1 and -2 chains are
unlikely. Most plasma membranes contain only modest levels of PUFA
that, even when appreciably elevated by dietary consumption, are
solely esteriﬁed to the sn-2 position while a saturated fatty acid is
retained at the sn-1 position [5]. Poor afﬁnity of cholesterol for PUFA
also drives these mixed chain PUFA-containing phospholipids to
segregate away from the sterol into domains. Mixtures of 16:0–
22:6PE, or 16:0–18:1PE as a control, with the lipid raft molecules SM
and cholesterol are the focus of attention in our investigations with
heteroacid saturated–polyunsaturated phospholipids. PE, which after
PC is the second most common phospholipid in mammalian plasma
membranes [4], was chosen for the DHA-containing phospholipid
because it is preferred over PC for uptake of the PUFA [25].
DSC of 16:0–22:6PE or 16:0–18:1PE in 1:1 mol mixtures with SM
shows that there is separation into PE-rich and SM-rich regions with
both DHA- and OA-containing phospholipids [81,82]. Two distinct
transitions centered at 8 and 24 °C are seen in the DSC scan for 16:0–
22:6PE/egg SM (1:1 mol) [81]. They are attributed to the melting ofphases rich in 16:0–22:6PE and SM, respectively. The de-mixing is
incomplete since the transition temperatures differ from those for the
individual lipids (Tm=2.2 °C for 16:0–22:6PE [83] and Tm=39.0 °C for
egg SM [84]). A similar interpretation applies to the DSC scan for 16:0–
18:1PE/egg SM. (1:1 mol) [81]. In this case the two transitions overlap
into a single broad exotherm, which may be deconvoluted to reveal a
transition at Tm=26.1 due to a 16:0–18:1PE-rich phase and another at
Tm=30.1 °C due to a SM-rich phase. Addition of cholesterol to either
16:0–22:6PE/SM or 16:0–18:1PE/SM in 1:1:1 mol concentration
smears out the transitions beyond detection, indicating that the sterol
interacts with PE as well as SM in both mixed systems [81,82]. A
substantial differential in interaction of cholesterol with DHA- and
OA-containing phospholipids is apparent when a low level of sterol
added. The higher-temperature, SM-rich peak in the DSC scan for
16:0–22:6PE/egg SM/cholesterol (1:1:0.005 mol) is obliterated while
the lower-temperature, 16:0–22:6PE-rich peak is unaffected [83]. In
contrast, the enthalpy of the broad single peak observed for 16:0–
18:1PE/egg SM (1:1 mol) is greatly diminished by the same amount of
sterol [83].
Greater separation from cholesterol for DHA- than OA-containing
phospholipids is observed in 1:1:1molmixtures with SM by detergent
extraction and solid state 2H NMR. The detergent extraction method
consists of incubating an aqueous dispersion of membranes in the
presence of a non-ionic detergent and then separating detergent
insoluble and soluble fractions by centrifugation [81,85]. Although
subject to potential artifacts [86], it is widely used to assess the
presence of domains in membranes and insolubility in cold non-ionic
detergents has historically served as a deﬁnition for lipid rafts
[3,11,16]. We compared phase separation between DRM, designated
raft, and detergent soluble membranes (DSM), designated non-raft, in
16:0–22:6PE/egg SM/cholesterol (1:1:1 mol) vs. 16:0–18:1PE/egg SM/
cholesterol (1:1:1 mol) membranes [81]. The results of experiments
conducted at 4 °C, where most detergent solubility studies are
performed, are plotted in Fig. 4. Qualitatively similar results were
obtained at 40 °C in experiments undertaken to more closely mimic
physiological temperature. In agreement with raft molecules being
detergent resistant, Fig. 4 conﬁrms that the DSM fraction for both
mixtures contains very little SM (b5%) or cholesterol (b10%). That a
considerable difference does exist in the amount of 16:0–22:6PE (70%)
and 16:0–18:1PE (22%) present in the DSM fraction is clear. The
aversion of PUFA for cholesterol is strong enough to cause themajority
of the DHA-containing phospholipid to partition into non-raft
domains that can be physically separated. The OA-containing
phospholipid, which does not possess such poor afﬁnity for the sterol,
is not excluded to the same extent from rafts.
The conclusion from DSC and detergent extraction experiments
that DHA-containing PE has a greater propensity than OA-containing
PE to segregate away from cholesterol in PE/SM mixed membranes is
corroborated by solid state 2H NMR work that, furthermore, gives
insight into the molecular architecture of domains. In these studies
analogs of PE ([2H31]16:0–22:6PE or [2H31]16:0–18:1PE) with a
perdeuterated sn-1 chain and SM ([2H31]-N-palmitoylsphingomyelin,
[2H31]16:0SM) with a perdeuterated amide-linked acyl chain are
employed to probe the molecular organization of each lipid in PE/SM
(1:1 mol) mixtures without and with cholesterol (1:1:1 mol) [81,82].
A comparison of average order parameters SCD derived from spectra
recorded at 35 °C is presented in Fig. 5. The smaller values measured
for [2H31]16:0–22:6PE vs. [2H31]16:0SM and [2H31]16:0–18:1PE vs.
[2H31]16:0SM in their respective mixed systems are attributed to the
formation of PE-rich, characterized by lower order, and SM-rich,
characterized by higher order, domains in the absence and presence
of cholesterol in both DHA- and OA-containing membranes.
Although order within PE- and SM-rich domains increases when
sterol is added to the two systems, the difference in order between
them becomes almost a factor of 3 bigger with DHA (0.208 vs. 0.291)
than OA (0.266 vs. 0.296). The aversion DHA, but not OA, has for
Fig. 5. Average order parameters SCD (left hand vertical scale) and average chain length
〈L〉 (right hand vertical scale) derived from 2H NMR spectra for [2H31]16:0–22:6PE/egg
SM (1:1 mol) and 16:0–22:6PE/[2H31]16:0SM (1:1 mol) and for [2H31]16:0–18:1PE/egg
SM (1:1 mol) and 16:0–18:1PE/[2H31]16:0SM (1:1 mol) in the absence and presence of
cholesterol (1:1:1 mol) at 35 °C [82].
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DHA-containing PE-rich domains and DHA is excluded from SM-rich/
sterol-rich domains, thus accentuating the distinction in order
between the domains. Physical insight into what the greater
differential in order means is revealed by estimates of the average
length 〈L〉 (right hand vertical scale) for [2H31]16:0 chains calculated
from the SCD values (left hand vertical scale) in Fig. 5. Assuming that
〈L〉 approximates to the thickness of a monolayer, the divergence
between the thickness of the bilayer in SM and PE-rich domains
increases from 1.3 to 3.2 Å when DHA replaces OA [82].Fig. 6. A cartoon depiction of our proposedmodel for themolecular mode of action for DHA. S
a DHA-rich non-raft domain from which cholesterol is excluded and further promotes the p
domain, the extreme opposite a raft, recruits a protein that requires such an environment to
structure of molecules. The purpose is to illustrate, with the aid of color-coding, the segregOnly a single spectral component is discernible for [2H31]16:0–
22:6PE, [2H31]16:0–18:1PE or [2H31]16:0SM in the spectra recorded
with PE/SM (1:1 mol) and PE/SM/cholesterol (1:1:1 mol) mixtures
despite incomplete demixing [81,82]. Therefore, the domains must be
small enough for lipid to exchange quickly between them and an
upper limit of b200 Å is assigned to the size on the basis of the
difference in average quadrupolar splitting in the domains [82]. A
comparable radius (b250 Å) was evaluated for 18:0–22:6PC/choles-
terol clusters in a similar analysis of 2H NMR spectra for deuterium
labeled phospholipid in 18:0–22:6PC/18:0–22:6PE/18:0–22:6PS/cho-
lesterol (4:4:1:1 mol) [63]. Fast exchange between domains was also
inferred from the spectra for deuterium labeled cholesterol in 16:0–
18:1PC/brain SM/cholesterol (1:1:1 mol) [87]. The possibility that the
presence of PUFA can trigger the formation of large (Nμm) from small
domains exists. Pulsed ﬁeld gradient (pfg) NMRmeasurements on PC/
egg SM/cholesterol (3:3:2 mol) membranes aligned between glass
plates using PC with a 18:0 acid sn-1 chain reveal two lipid lateral
diffusion coefﬁcients, ascribed to lo and ld phases, when 20:4 or 22:6,
but not 18:1 and 18:2, acid is at the sn-2 position [49].
The tremendous diversity of disease states alleviated by dietary
consumption of PUFA, notably DHA, implies a fundamental mode of
action common to most cells. A likely site is the plasma membrane
where PUFA incorporate into phospholipids. We hypothesize that
lateral sequestration of PUFA-containing phospholipids into domains
away from cholesterol is, in part, the molecular origin of the
mechanism responsible [5,10,48,62,78]. Fig. 6 illustrates our hypothe-
sis in a cartoon. In the leaﬂet of a membrane that, for the sake of
simplicity, is initially devoid of PUFA there is a lipid raft ﬂoating in a
sea of bulk lipid (Fig. 6, upper). SM and cholesterol are both enriched
in the raft and distributed at low concentration throughout the bulk
lipid environment. Replacing bulk lipid by DHA-containing phospho-
lipid creates a DHA-rich (non-raft) domain from which cholesterol is
excluded and, together with sphingolipid, driven to further segregateubstituting DHA-containing phospholipid for bulk lipid in the plasmamembrane creates
artitioning of the sterol and SM into a larger lipid raft. The highly disordered DHA-rich
function. This skeletal cartoon is not meant to represent the actual three-dimensional
ation of lipids into raft (“red”) and non-raft (“blue”) domains.
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environment to function is recruited to the DHA-rich domain, while
the enlarged raft can accommodate another resident protein.
A novel paradigm that we now introduce into our model is to
postulate a structural role for α-tocopherol, the major component of
vitamin E. The presumptive role for α-tocopherol within membranes
is to prevent lipid peroxidation that would result in functional
impairment [88]. Lipid peroxidation, for instance, contributes to the
development of cardiovascular diseases [89,90]. How, when present
in only small amount (b1 mol%) [88], the vitamin can efﬁciently
fulﬁll this role is an unresolved question. As depicted in Fig. 6, we
propose that α-tocopherol and DHA-containing phospholipids co-
localize in domains. This arrangement would produce a local
concentration ampliﬁcation optimizing protection of the lipid
component most susceptible to oxidation. Preferential afﬁnity of α-
tocopherol for PUFA, the complete opposite of the situation for
cholesterol, is the underpinning mechanism. While strong attraction
of the sterol for SM confers stability on lipid rafts, we propose that
the vitamin not only prevents oxidation in PUFA-rich non-raft
domains but is also the “glue” that holds them together. An
appreciation of the strikingly similar yet profoundly different
molecular structure of the vitamin and sterol provides insight [91].
Like cholesterol, α-tocopherol consists of a rigid ring structure
(chromanol group) that possesses a polar-OH group and a phytyl
sidechain. Unlike cholesterol, the smaller chromanol group avoids
the adverse interaction with the highly disordered sequence of
double bonds in PUFA experienced by the steroid moiety. Experi-
ments are currently underway to test this proposal.
7. Conclusion
PUFA, DHA representing the most extreme example, rapidly inter-
convert through a wide range of conformations. This high disorder
deters close proximity to the rigid steroid moiety of cholesterol, so
that PUFA-containing phospholipids tend to push cholesterol away
and to laterally segregate into PUFA-rich/sterol-poor domains within
membranes. This picture is supported by the work on model
membranes reviewed in this article. We hypothesize that the health
beneﬁts associated with DHA may be, in part, ascribed to the
formation of DHA-rich domains in the plasma membrane. These
domains, which are organizationally the antithesis of lipid rafts,
recruit and serve as the platform for proteins that require a highly
disordered environment to function.
Acknowledgements
It is a pleasure to thank M. R. Brzustowicz, S. R. Shaikh, D. S.
LoCascio and S. P. Soni, who were or are colleagues at IUPUI, and M.
Caffrey, V. Cherezov, R. A. Siddiqui, T. A. Harroun and J. Katsaras, who
are collaborators at other institutions, for their contribution to the
research presented in this review. We also thank K. Crosby and H.
Petrache for assistance with ﬁgures.
References
[1] M. Edidin, Patches and fences: probing for plasma membrane domains, J. Cell Sci.
(Suppl. 17) (1993) 165–169.
[2] M. Edidin, Shrinking patches and slippery rafts: scales of domains in the plasma
membrane, Trends Cell Biol. 11 (2001) 493–496.
[3] M. Edidin, The state of lipid rafts: from model membranes to cells, Annu. Rev.
Biophys. Biomol. Struct. 32 (2003) 257–283.
[4] R.B. Gennis, Biomembranes: Molecular Structure and Function, Springer-Verlag,
New York, 1989.
[5] W. Stillwell, S.R. Wassall, Docosahexaenoic acid: membrane properties of a unique
fatty acid, Chem. Phys. Lipids 126 (2003) 1–27.
[6] N. Salem Jr., H.Y. Kim, J.A. Yergey, Docosahexaenoic acid: membrane function and
metabolism, in: A.P. Simopoulos, R.R. Kifer, R. Martin (Eds.), The Health Effects of
Polyunsaturated Fatty Acids in Seafoods, Academic Press, New York, 1986, pp.
317–363.[7] W. Stillwell, Docosahexaenoic acid: a most unusual fatty acid, Chem. Phys. Lipids
153 (2008) 1–2.
[8] W. Stillwell, The role of polyunsaturated lipids inmembrane raft function, Scand. J.
Food Nutr. 50 (Suppl. 2) (2006) 107–113.
[9] T.E. Thompson, T.W. Tillack, Organization of glycosphingolipids in bilayers and
plasma membranes of mammalian cells, Annu. Rev. Biophys. Biophys. Chem. 14
(1985) 361–386.
[10] S.R.Wassall,M. Caffrey, V. Cherezov,M.R. Brzustowicz, S.R. Shaikh,W. Stillwell, Order
from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated
lipids in membrane raft formation, Chem. Phys. Lipids 132 (2004) 79–88.
[11] K. Simons, E. Ikonnen, Functional rafts in cell membranes, Nature 389 (1997)
569–572.
[12] D. Brown, E. London, Structure and origin of ordered lipid domains in biological
membranes, J. Membr. Biol. 164 (1998) 103–114.
[13] L.J. Pike, Rafts deﬁned: a report on the Keystone symposium on lipid rafts and cell
function, J. Lipid Res. 17 (2006) 1597–1598.
[14] S.N. Ahmed, D.A. Brown, E. London, On the origin of sphingomyelin/cholesterol-
rich detergent-insoluble cell membranes: physiological concentrations of choles-
terol and sphingolipid induce formation of a detergent-insoluble, liquid ordered
lipid phase in model membranes, Biochemistry 36 (1997) 10944–10953.
[15] D.A. Brown, E. London, Structure of detergent-resistant membrane domains: does
phase separation occur in biological membranes? Biochem. Biophys. Res.
Commun. 240 (1997) 1–7.
[16] D.A. Brown, E. London, Structure and function of sphingolipid- and cholesterol-
rich membrane rafts, J. Biol. Chem. 275 (2000) 17221–17224.
[17] Y. Liu, L. Casey, L.J. Pike, Compartmentalization of phosphatidylinositol 4,5-
bisphosphate in low-density membrane domains in the absence of caveolin,
Biochem. Biophys. Res. Commun. 245 (1998) 684–690.
[18] W.C. Breckenridge, G. Gombos, L.G. Morgan, The lipid composition of adult rat
brain synaptosomal membranes, Biochim. Biophys. Acta 266 (1972) 695–707.
[19] A.R. Neill, C.J. Masters, Metabolism of fatty acids by bovine spermatozoa, J. Reprod.
Fertil. 34 (1973) 279–287.
[20] R.D. Wiegand, R.E. Anderson, Phospholipid molecular species of frog rod outer
segment membranes, Exp. Eye Res. 37 (1983) 159–173.
[21] G.P. Miljanich, L.A. Sklar, D.L. White, E.A. Dratz, Disaturated and dipolyunsaturated
phospholipids in the bovine retinal rod outer segment disk membrane, Biochim.
Biophys. Acta 552 (1979) 294–306.
[22] M.V. Bell, J.R. Dick, C. Buda, Molecular speciation of ﬁsh sperm phospholipids:
large amounts of dipolyunsaturated phosphatidylserine, Lipids 32 (1997)
1085–1091.
[23] L.J. Jenski, L.K. Sturdevant, W.D. Ehringer, W. Stillwell, Omega-3 fatty increase
spontaneous release of cytosolic components from tumor cells, Lipids 26 (1991)
353–358.
[24] R.E. Anderson, L. Sperling, Lipids of the ocular tissue VII. Positional distribution of
the fatty acids in the phospholipids of bovine rod outer segments, Arch. Biochem.
Biophys. 144 (1971) 673–677.
[25] M. Zerouga,W. Stillwell, J. Stone, A. Powner, A.C. Dumaual, L.J. Jenski, Phospholipid
class as a determinant in docosahexaenoic acid's effect on tumor cell viability,
Anticancer Res. 16 (1996) 2863–2868.
[26] W. Stillwell, L.J. Jenski, F.T. Crump, W. Ehringer, Effect of docosahexaenoic acid on
mouse mitochondrial membrane properties, Lipids 32 (1997) 497–506.
[27] Q.S. Tahin, M. Blum, E. Carafoli, The fatty acid composition of subcellular
membranes of rat liver, heart, and brain: diet-induced modiﬁcations, Eur. J.
Biochem. 121 (1981) 5–13.
[28] D.R. Robinson, L.-L. Xu, C.T. Knoell, S. Tateno, W. Olesiak, Modiﬁcation of spleen
phospholipid fatty acid composition by dietary ﬁsh oil and by n−3 fatty acid ethyl
esters, J. Lipid Res. 34 (1993) 1423–1434.
[29] P. Emmelot, R.P. van Hoeven, Phospholipid unsaturation and plasma membrane
organization, Chem. Phys. Lipids 14 (1975) 236–246.
[30] N. Salem Jr., P. Bougnoux, Asymmetry of phosphatidylethanolamine molecular
species in the human lymphocyte plasma membrane, 24th Intl. Conf. Biochem.
Lipids (1983) 44.
[31] H.R. Knapp, F. Hullin, N. Salem Jr., Asymmetric incorporation of dietary n−3 fatty
acids into membrane aminophospholipids of human erythrocytes, J. Lipid Res. 35
(1994) 1283–1291.
[32] K.R. Applegate, J.A. Glomset, Computer-based modeling of the conformation and
packing properties of docosahexaenoic acid, J. Lipid Res. 27 (1986) 658–680.
[33] K.R. Applegate, J.A. Glomset, Effect of acyl chain unsaturation on the conformation
of model diacylglycerols: a computer modeling study, J. Lipid Res. 32 (1991)
1635–1644.
[34] S.E. Feller, Acyl chain conformations in phospholipid bilayers: a comparative study
of docosahexaenoic acid and saturated fatty acids, Chem. Phys. Lipids 153 (2008)
76–80.
[35] O. Soubias, K. Gawrisch, Docosahexaenoyl chains isomerize on the sub-
nanosecond time scale, J. Am. Chem. Soc. 129 (2007) 6678–6679.
[36] L. Saiz, M.L. Klein, Structural properties of a highly polyunsaturated lipid bilayer
from molecular dynamics simulations, Biophys. J. 81 (2001) 204–216.
[37] T. Huber, K. Rajamoorthi, V.F. Kurze, K. Beyer, M.F. Brown, Structure of
docosahexaenoic acid-containing phospholipid bilayers as studied by 2H NMR
and molecular dynamics simulations, J. Am. Chem. Soc. 124 (2002) 298–309.
[38] S.E. Feller, K. Gawrisch, A.D. MacKerrell Jr., Polyunsaturated fatty acids in lipid
bilayers: intrinsic and environmental contributions to their unique physical
properties, J. Am. Chem. Soc. 124 (2002) 318–326.
[39] S.R. Shaikh, M.R. Brzustowicz, W. Stillwell, S.R. Wassall, Formation of inverted
hexagonal phase in SDPE as observed by solid-state 31P NMR, Biochem. Biophys.
Res. Commun. 286 (2001) 758–763.
32 S.R. Wassall, W. Stillwell / Biochimica et Biophysica Acta 1788 (2009) 24–32[40] R.M. Epand, Lipid polymorphism and protein–lipid interactions, Biochim. Biophys.
Acta 1367 (1998) 353–368.
[41] J.M. Smaby, M.M. Momsen, H.L. Brockman, R.E. Brown, Phosphatidylcholine acyl
unsaturation modulates the decrease in interfacial elasticity induced by
cholesterol, Biophys. J. 73 (1997) 1492–1505.
[42] B.W. Koenig, H.H. Strey, K. Gawrisch, Membrane lateral compressibility deter-
mined by NMR and X-ray diffraction: effect of acyl chain polyunsaturation,
Biophys. J. 73 (1997) 1954–1966.
[43] N.V. Eldho, S.E. Feller, S. Tristram-Nagle, I.V. Polozov, K. Gawrisch, Polyunsaturated
docosahexaenoic vs. docosapentaenoic acid — differences in lipid matrix proper-
ties from the loss of one double bond, J. Am. Chem. Soc. 125 (2003) 6409–6421.
[44] E.A. Dratz, J.F. van Breeman, K.M. Kamps, W. Keegstra, E.F. van Bruggen, Two-
dimensional crystallization of bovine rhodopsin, Biochim. Biophys. Acta 832
(1985) 337–342.
[45] D. Huster, A.J. Jin, K. Arnold, K. Gawrisch, Water permeability of polyunsaturated
lipid membranes measured by 17O NMR, Biophys. J. 73 (1997) 855–864.
[46] W. Stillwell, W.D. Ehringer, L.J. Jenski, Docosahexaenoic acid increases perme-
ability of lipid vesicles and tumor cells, Lipids 28 (1993) 103–108.
[47] V.T. Armstrong, M.R. Brzustowicz, S.R. Wassall, L.J. Jenski, W. Stillwell, Rapid ﬂip-
ﬂop in polyunsaturated (docosahexaenoate) phospholipid membranes, Arch.
Biochem. Biophys. 414 (2003) 74–82.
[48] W. Stillwell, S.R. Shaikh, D. LoCascio, R.A. Siddiqui, J. Seo, R.S. Chapkin, S.R. Wassall,
Docosahexaenoic acid: an important membrane-altering omega-3 fatty acid, in:
J.D. Huamg (Ed.), Frontiers in Nutrition Research, Chap.8, Nova Science
Publishers, Hauppauge, NY, 2006, pp. 249–271.
[49] A. Filippov, G. Orädd, G. Lindblom, Domain formation in model membranes
studied by pulsed-ﬁeld gradient-NMR: the role of lipid polyunsaturation, Biophys.
J. 93 (2007) 182–190.
[50] P. Yeagle, The Membranes of Cells, Academic Press, Orlando, 1987.
[51] J.R. Silvius, Role of cholesterol in lipid raft formation: lessons from lipid model
systems, Biochim. Biophys. Acta 1610 (2003) 174–183.
[52] L. Finegold (Ed.), Cholesterol in Membrane Models, CRC Press, Boca Raton, 1993.
[53] M.R. Vist, J.H. Davis, Phase equilibria of cholesterol/dipalmitoylphosphatidylcho-
line mixtures: 2H nuclear magnetic resonance and differential scanning
calorimetry, Biochemistry 29 (1990) 451–464.
[54] J. Huang, J.T. Buboltz, G.W. Feigenson, Maximum solubility of cholesterol in
phosphatidylcholine and phosphatidylethanolamine bilayers, Biochim. Biophys.
Acta 1417 (1999) 89–100.
[55] A. Léonard, C. Escriv, M. Laguerre, E. Pebay-Peyroula,W. Néri, T. Pott, J. Katsaras, E.J.
Dufourc, Location of cholesterol in DMPC membranes. A comparative study by
neutron diffraction and molecular mechanics simulation, Langmuir 17 (2001)
2019–2030.
[56] M.P. Marsan, L. Muller, C. Ramos, F. Rodriguez, F.J. Dufourc, J. Czaplicki, A. Milon,
Cholesterol orientation and dynamics in dimyristoylphosphatidylcholine bilayers:
a solid state deuterium NMR analysis, Biophys. J. 76 (1999) 351–359.
[57] J.L. Thewalt, M. Bloom, Phosphatidylcholine: cholesterol phase diagrams, Biophys.
J. 63 (1992) 1176–1181.
[58] T.A. Harroun, J. Katsaras, S.R. Wassall, Cholesterol hydroxyl group is found to
reside in the center of a polyunsaturated lipid membrane, Biochemistry 45 (2006)
1227–1233.
[59] M.R. Brzustowicz, W. Stillwell, S.R. Wassall, Molecular organization of cholesterol
in polyunsaturated phospholipids membranes: a solid state 2H NMR investigation,
FEBS Lett. 451 (1999) 197–202.
[60] D.C. Mitchell, B.J. Litman, Effect of cholesterol on molecular order and dynamics in
highly polyunsaturated phospholipid bilayers, Biophys. J. 75 (1998) 896–908.
[61] C.S. Jackman, P.J. Davis, M.R. Morrow, K.M. Keough, Effect of cholesterol on the
chain-ordering transition of 1-palmitoyl-2-arachidonoyl phosphatidylcholine, J.
Phys. Chem. B. 103 (1999) 8830–8836.
[62] S.R. Wassall, W. Stillwell, Docosahexaenoic acid domains: the ultimate non-raft
membrane domain, Chem. Phys. Lipids 153 (2008) 57–63.
[63] D. Huster, K. Arnold, K. Gawrisch, Inﬂuence of docosahexaenoic acid and
cholesterol on lateral lipid organization in phospholipid mixtures, Biochemistry
37 (1998) 17299–17308.
[64] M.C. Pitman, F. Suits, A.D. MacKerell Jr., S.E. Feller, Molecular-level organization of
saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer
containing cholesterol, Biophys. J. 43 (2004) 15318–15328.
[65] C.H. Huang, A structural model for the cholesterol–phosphatidylcholine com-
plexes in bilayer membranes, Lipids 12 (1977) 348–356.
[66] S.A. Pandit, S-W. Chiu, E. Jakobson, A. Grama, H.L. Scott, Cholesterol packing
around lipids with saturated and unsaturated chains: a simulation study,
Langmuir 24 (2008) 6858–6865.[67] R.A. Demel, W.S.M. Geurts van Kessel, L.L.M. van Deenen, The properties of
polyunsaturated lecithins in monolayers and liposomes and the interaction of
these lecithins with cholesterol, Biochim. Biophys. Acta 266 (1972) 26–40.
[68] D. Ghosh, M.A. Williams, J. Tinoco, The inﬂuence of lecithin structure on their
monolayer behavior and interactions with cholesterol, Biochim. Biophys. Acta 291
(1973) 351–362.
[69] W. Stillwell, W.D. Ehringer, A.C. Dumaual, S.R. Wassall, Cholesterol condensation
of α-linolenic and γ-linolenic acid-containing phosphatidylcholine monolayers
and bilayers, Biochim. Biophys. Acta 1214 (1994) 131–136.
[70] S.L. Niu, B.J. Litman, Determination of membrane cholesterol partition
coefﬁcient using a lipid vesicle-cyclodextrin binary system: effect of phospho-
lipid acyl chain unsaturation and headgroup composition, Biophys. J. 83 (2002)
3408–3415.
[71] M.R. Brzustowicz, V. Cherezov, M. Caffrey, W. Stillwell, S.R. Wassall, Molecular
organization of cholesterol in polyunsaturated membranes: microdomain forma-
tion, Biophys. J. 82 (2002) 285–298.
[72] M.R. Brzustowicz, V. Cherezov, M. Zerouga, M. Caffrey, W. Stillwell, S.R. Wassall,
Controlling membrane cholesterol content: a role for polyunsaturated (docosa-
hexaenoate) phospholipids, Biochemistry 41 (2002) 12509–12519.
[73] S.R. Shaikh, V. Cherezov, M. Caffrey, W. Stillwell, S.R. Wassall, Interaction of
cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine:
trigger for microdomain/raft formation? Biochemistry 42 (2003) 12028–12037.
[74] S.R. Shaikh, V. Cherezov, M. Caffrey, S.P. Soni, D. LoCascio, W. Stillwell, S.R. Wassall,
Molecular organization of cholesterol in unsaturated phosphatidylethanolamines:
X-ray diffraction and solid state 2H NMR reveal differences with phosphatidyl-
cholines, J. Am. Chem. Soc. 128 (2006) 5375–5383.
[75] T.A. Harroun, J. Katsaras, S.R. Wassall, Cholesterol is found to reside in the center of
a polyunsaturated lipid membrane, Biochemistry 47 (2008) 7090–7096.
[76] S.J. Marrink, A.H. de Vries, T.A. Harroun, J. Katsaras, S.R. Wassall, Cholesterol shows
preference for the interior of polyunsaturated lipid membranes, J. Am. Chem. Soc.
130 (2008) 10–11.
[77] W.D. Sweet, F. Schroeder, Polyunsaturated fatty acids alter sterol transbilayer
domains in LM ﬁbroblast plasma membrane, FEBS Lett. 229 (1988) 188–192.
[78] W. Stillwell, S.R. Shaikh, M. Zerouga, R.A. Siddiqui, J. Seo, S.R. Wassall,
Docosahexaenoic acid affects cell signaling by altering lipid rafts, Reprod. Nutr.
Dev. 45 (2005) 559–579.
[79] S.R. Shaikh, M.A. Edidin, Membranes are not just rafts, Chem. Phys. Lipids 144
(2006) 1–3.
[80] A. Polozova, B.J. Litman, Cholesterol dependent recruitment of di22:6-PC by a G
protein-coupled receptor into lateral domains, Biophys. J. 79 (2000) 2632–2643.
[81] S.R. Shaikh, A.C. Dumaual, A. Castillo, D. LoCascio, R.A. Siddiqui, W. Stillwell, S.R.
Wassall, Oleic and docosahexaenoic acid differentially phase separate from lipid
raft molecules: a comparative NMR, DSC, AFM, and detergent extraction study,
Biophys. J. 87 (2004) 1752–1766.
[82] S.P. Soni, D.S. LoCascio, Y. Liu, J.A. Williams, R. Bittman, W. Stillwell, S.R. Wassall,
Docosahexaenoic acid enhances segregation of lipids between raft and non-raft
domains: 2H NMR study, Biophys. J. 95 (2008) 203–214.
[83] S.R. Shaikh, M.R. Brzustowicz, N. Gustafson, W. Stillwell, S.R. Wassall,
Monunsaturated PE does not phase separate from the lipid raft molecules
sphingomyelin and cholesterol: role for polyunsaturation? Biochemistry 41
(2002) 10593–10602.
[84] D.A. Mannock, T.J. McIntosh, X. Jiang, D.F. Covey, R.N. McElhaney, Effects of natural
and enantiomeric cholesterol on the thermotropic phase behavior and structure
of egg sphingomyelin bilayer membranes, Biophys. J. 84 (2003) 1038–1046.
[85] S.R. Shaikh, A.C. Dumaual, D. LoCascio, R.A. Siddqui, W. Stillwell, Acyl chain
unsaturation in PEs modulates phase separation from lipid raft molecules,
Biochem. Biophys. Res. Commun. 311 (2003) 793–796.
[86] H. Heerklotz, Triton promotes domain formation in lipid raft mixtures, Biophys. J.
83 (2002) 2693–2701.
[87] F. Aussenac, M. Tavares, E.J. Dufourc, Cholesterol dynamics in membranes of raft
composition: a molecular point of view from 2H and 31P solid-state NMR,
Biochemistry 42 (2003) 1383–1390.
[88] J. Atkinson, R.F. Epand, R.M. Epand, Tocopherols and tocotrienols in membranes: a
critical review, Free Rad. Biol. Med. 44 (2008) 739–764.
[89] W.A. Pryor, Vitamin E and heart disease: basic science to clinical intervention
trials, Free Rad. Biol. Med. 28 (2000) 141–164.
[90] D. Bron, R. Asmis, Vitamin E and the prevention of atherosclerosis, Int. J. Vitam.
Nutr. Res. 71 (2001) 18–24.
[91] W. Stillwell, T.D. Dallman, A.C. Dumaual, F.T. Crump, L.J. Jenski, Cholesterol versus
α-tocopherol: effects on properties of bilayers made from heteroacid phospha-
tidylcholines, Biochemistry 35 (1996) 13353–13362.
